Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Emerald Health Therapeutics Inc TBQBF


Primary Symbol: EMHTF

Emerald is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis products with an emphasis on innovation and production excellence.


OTCQB:EMHTF - Post by User

Post by Looneeon Mar 14, 2019 8:34pm
250 Views
Post# 29488627

Richmond facility

Richmond facilitySeems to me that Emerald is focused on their Quebec and Richmond facilities at the moment with PSF now at 1.1m sq ft. so no need to expand D2 etc atm.  As per below, Ricmond is costing $20M and expected completion end of June.

Facilities Verdlite. Verdlite Holdings owns and Verdlite operates an 88,000 square foot facility in Saint – Eustache, Quebec, which is expected to be in full production by mid-2019. The Company budgeted $13 million for the completion of the facility, of which $7.4 million has been spent to date installing partitioning walls, HVAC, electrical, plumbing, environmental control and security systems, processing areas, to prepare it for cultivating and processing cannabis in compliance with the requirements of the Cannabis Act.

The Joint Venture. The Joint Venture owns and operates a 1.1-million square foot Delta 3 greenhouse (the "JV Facility") in Delta, British Columbia of which the Joint Venture's cultivation licence currently permits it to produce cannabis in approximately 1.03 million square feet. The Joint Venture has incurred approximately $58 million upgrading and retrofitting the JV Facility, removing tomato growing equipment and fixtures and installing partitioning walls, HVAC, electrical, plumbing, environmental control and security systems, nursery structures, processing areas, a vault, and shade systems to prepare it for cultivating and processing cannabis in compliance with the requirements of the Cannabis Act. The facility is substantially complete now.
.
Avalite. Avalite owns and operates a 3,742 square foot facility located in Langley, British Columbia at which chemical analyses and testing of cannabis products is conducted.
.
Victoria. The Company leases 16,000 square feet of mixed-use space in Victoria, British Columbia with approximately 500 square feet of cultivation area with the balance dedicated to laboratory and packaging activities and the Company's national call centre for customer service.
.
Richmond. The Company is constructing a 150,000 square foot facility in Richmond, British Columbia. Construction originally commenced in May 2017. The Company estimates that it will incur a total of $20 million installing partitioning walls, HVAC, electrical, plumbing, environmental control and security systems, nursery structures, processing areas, a vault, and shade systems to prepare it for cultivating and processing cannabis in compliance with the requirements of the Cannabis Act. The Company has incurred expenses related to this facility of approximately $13 million and approximately $7 million of additional construction costs are expected to be incurred to complete the facility. The facility is expected to be substantially complete by June 30, 2019.
<< Previous
Bullboard Posts
Next >>